BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36563771)

  • 1. Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus.
    Erazo-Martínez V; Tobón GJ; Cañas CA
    Autoimmun Rev; 2023 Feb; 22(2):103262. PubMed ID: 36563771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
    Robinson ES; Werth VP
    Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.
    Abernathy-Close L; Lazar S; Stannard J; Tsoi LC; Eddy S; Rizvi SM; Yee CM; Myers EM; Namas R; Lowe L; Reed TJ; Wen F; Gudjonsson JE; Kahlenberg JM; Berthier CC
    Front Immunol; 2021; 12():775353. PubMed ID: 34868043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
    Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
    J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
    Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
    Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory and T Helper 17/ Regulatory T Cells Related Cytokines Balance in Cutaneous Lupus Erythematosus (CLE).
    Yazdani MR; Aflaki E; Gholijani N
    Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):9-17. PubMed ID: 32245325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
    Zhang YP; Wu J; Han YF; Shi ZR; Wang L
    Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin CD4
    Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
    J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
    Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
    Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
    Yu C; Chang C; Zhang J
    J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
    Foulke G; Helm LA; Clebak KT; Helm M
    FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-α stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus.
    Zahn S; Rehkämper C; Ferring-Schmitt S; Bieber T; Tüting T; Wenzel J
    Br J Dermatol; 2011 Nov; 165(5):1118-23. PubMed ID: 21711324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in cutaneous lupus.
    Maz MP; Martens JWS; Hannoudi A; Reddy AL; Hile GA; Kahlenberg JM
    J Autoimmun; 2022 Oct; 132():102865. PubMed ID: 35858957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tight correlation of 5-hydroxymethylcytosine expression with the scarring damage of discoid lupus erythematosus.
    Li Q; Yang M; Chen K; Zhou S; Zhou S; Wu H
    Lupus; 2022 Oct; 31(11):1306-1316. PubMed ID: 35817588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
    Cho YM; Furie R
    Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review.
    Kuhn A; Wenzel J; Weyd H
    Clin Rev Allergy Immunol; 2014 Oct; 47(2):148-62. PubMed ID: 24420508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis of keratinocytes and serum DNase I activity in patients with cutaneous lupus erythematosus: relationship with clinical and immunoserological parameters.
    Skiljevic D; Bonaci-Nikolic B; Brasanac D; Nikolic M
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):523-529. PubMed ID: 27557471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.
    Meller S; Winterberg F; Gilliet M; Müller A; Lauceviciute I; Rieker J; Neumann NJ; Kubitza R; Gombert M; Bünemann E; Wiesner U; Franken-Kunkel P; Kanzler H; Dieu-Nosjean MC; Amara A; Ruzicka T; Lehmann P; Zlotnik A; Homey B
    Arthritis Rheum; 2005 May; 52(5):1504-16. PubMed ID: 15880822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1β and IL-17 in cutaneous lupus erythematous skin biopsies: could immunohistochemicals indicate a tendency towards systemic involvement?
    Lovato BH; Fogagnolo L; Souza EM; Silva LJBD; Velho PENF; Cintra ML; Teixeira F
    An Bras Dermatol; 2024; 99(1):66-71. PubMed ID: 37783618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.